Bridge Neurotech Inc.

Bridge Neurotech is developing a non-invasive brain-computer interface based on functional ultrasound imaging, placing it in a field that also includes companies such as Neuralink and Synchron. Those companies are associated with implantable approaches, while Bridge Neurotech’s stated differentiator is capturing and decoding brain activity without surgery or physical modification to the body. Its platform spans custom ultrasound hardware, real-time imaging, and AI-based neural decoding, so it is building across both device and software layers rather than offering only an analysis tool. The October 6, 2026 partnership with Butterfly Network adds an established ultrasound technology collaborator to its development effort. With a 1–10 employee range and a reported $13.5 million Seed round, Bridge Neurotech remains an early-stage entrant; its competitive position will depend on demonstrating reliable signal capture, useful decoding, and practical research or healthcare workflows.

Bridge Neurotech’s growth profile is at an early development stage. The company is listed as founded in 2026 and has a reported $13.5 million Seed round, backed by General Catalyst, reMind Capital, Sunflower Capital, and Scott Sandell. The round’s announcement date is unavailable, so the funding cannot be placed more precisely on its timeline. Its October 6, 2026 partnership with Butterfly Network is the clearest dated inflection point: the two companies aim to develop a fully non-invasive brain-computer interface. That collaboration aligns with Bridge Neurotech’s focus on functional ultrasound and may support the hardware and imaging side of its platform, though no delivery milestones or results have been reported here. The company’s 1–10 employee range and hiring across ultrasound imaging science, machine learning, electrical engineering, and hardware suggest it is assembling capabilities to develop an integrated system. A first human research study in Redwood City has been described as planned, but its current status and timing are not confirmed.